newsletter masthead
July 5, 2019
Using Artificial Intelligence to Deliver Personalized Radiation Therapy
Results from a new study led by Cleveland Clinic andpublished in  Lancet Digital Health  show that an artificial intelligence (AI) framework can provide individualized radiation dose delivery based on data from patient computerized tomography (CT) scans and electronic health records. This AI framework is the first to use medical scans to inform radiation dose delivery, moving the field forward from using generic dose prescriptions to more personalized treatments. 

"While highly effective in many clinical settings,
radiotherapy can greatly benefit from
dose delivery  optimization. This framework will help physicians  develop data-driven, personalized dosage schedules that can maximize the likelihood of treatment success and mitigate radiation side effects for patients," says  Mohamed Abazeed, MD, PhD , practicing radiation oncologist, Case CCC  member and lead author on the study.  more>
Huang Awarded $100K as MIB Agents OutSmarting Osteosarcoma Winner 
The Case Comprehensive Cancer Center extends congratulations to Alex Huang, MD, PhD for his successful proposal, "New Immune-Mediated 
Alex Huang
Therapies for Lung Osteosarcoma" which secured a $100,000 award from MIB Agents. Huang will also be presenting a Keynote at the MIB Agents' FACTOR Osteosarcoma conference in 2020.
Join Team Case CCC for VeloSano 6: Cheer, Volunteer, Donate or Ride!

Bike to Cure month is here! The weekend of July 19-21, our team will mount their bikes at the 6th VeloSano Bike to Cure Weekend! To-date, Team Case CCC has 75 members who are committed to cancer research, prevention, treatment and cures and have  raised $32,374 and counting. We've grown by 5 members and raised $2,926 in the past week!

While we are still welcoming riders to our team, you can also get involved by volunteering for our cheer station or donating to any rider or the team as a whole to show your support!
Deadline Approaching for Fall Admission for Two-Year Master's Level Program in Regenerative Medicine and Entrepreneurship
The RGME is the first two-year master's level program in Ohio focused on Regenerative Medicine and Entrepreneurship.

Students enrolled in the RGME program will have access to cutting-edge clinical and research facilities along with small biotechnology companies within the network of the National Center for Regenerative Medicine (NCRM).

This unique, interdisciplinary program will provide a rigorous educational pathway targeting individuals seeking the advanced skills and training required to excel in the unique workforce necessary to support the exponential growth and application of the field of regenerative medicine. The Master's program in RGME will train individuals to work in academic, commercial, and clinical settings to support cellular manufacturing, biotechnology innovation, legal and compliance, financial analyst and venture capital, and business development activities taking advantage of our strengths across the disciplines of regenerative medicine as a whole.  Submit applications by August 1, 2019 for consideration of the Fall 2019 term. Learn more>
Case Comprehensive Cancer Center Annual Scientific Retreat
This month, our entire center will come together - one of the few times a year we have the opportunity to do so - to collaborate and enjoy each other's company at the center's Annual Scientific Retreat July 25 and 26.

The retreat agenda is now available with TED-style talks from prominent Cleveland research leaders, a reception, keynote, scientific presentations and breakout sessions for programs that you won't want to miss!

All students, postdocs, and fellows conducting cancer research are invited to  submit abstracts by today for the retreat. Cancer Center leadership will review abstracts based on the relationship to cancer, novelty, significance of findings and clarity.  Register for retreat today>
Registration Now Open: Artificial Intelligence in Oncology Symposium
Oct 24, 2019 | Tinkham Veale University Center

On October 24, the Case Comprehensive Cancer Center will host the inaugural Artificial Intelligence in Oncology Symposium: Advancements in Policy at Case Western Reserve University.

The symposium will bring together experts in AI and machine learning  as well as clinical, industry and federal agency experts in pathology, radiology, oncology and immuno-oncology to speak on research developments, regulatory policy, reimbursement and ethics surrounding AI.

Symposium Highlights:
  • Focused panel discussions
  • Networking opportunities
  • Exhibitions available throughout the day
Be sure to register by August 30, 2019 to secure our discounted early bird registration. A discounts for students and trainees who wish to attend is available. We look forward to seeing you in October!  Save your seat>
Innovators in AYA Cancer: Driving Science and Policy toward a Brighter Future for Teens and Young Adults with Cancer
Nov 14-15, 2019 | Tinkham Veale University Center
Registration will be opening soon for the Case Comprehensive Cancer Center's AYA Oncology Symposium taking place November 14-15, 2019 at Tinkham Veale University Center at Case Western Reserve University! Sign up to receive updates>
Open Funding Opportunities at the Case Comprehensive Cancer Center
The Case Comprehensive Cancer Center is currently  accepting applications for the following Case CCC logo additional funding opportunities. Click each opportunity for award descriptions, funding criteria and application instructions.
AACR and Stand Up to Cancer Gastric Cancer Interception Research Team Grant
LOI Deadline: July 30, 2019
Proposal Deadline: Aug 30, 2019

The American Association for Cancer Research is AACR logo accepting applications for the Stand Up tot Cancer  Gastric Cancer Interception Research Team Grant, offering $3 million over 3 years for innovative projects focused on gastric cancer interception.

The Stand Up To Cancer Gastric Cancer Interception Research Team Grant represents a new, focused effort to implement advances in gastric cancer interception and prevention research as rapidly as possible through the creation of a collaborative, translational, cancer "Research Team". The most talented and promising researchers across institutions will be assembled into a Research Team, forming an optimal configuration of expertise needed to solve key problems in gastric cancer interception and prevention research. This Research Team will span multiple disciplines within and beyond the gastric oncology community, ideally including investigators with expertise outside the biological sciences, and utilize new tools to answer research questions in a coordinated way. View program guidelines, eligibility criteria and application instructions>
Sartorius and Science Prize for Regenerative Medicine and Cell Therapy
Deadline: Oct 1, 2019

The Sartorius & Science Prize for Regenerative Medicine& Cell Therapy is an annual prize aimed at supporting and encouraging scientists focused on basic or translational research that advances
medical progress in regenerative medicine and cell therapy. Established in 2017, the prize is awarded for outstanding research performed by the applicant and as a mutual endeavor to raise awareness for the field and its fundamental significance for our future.

The Grand Prize winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is awarded $25,000 and a publication of his or her essay in Science (print & online). Also, up to three runners-up will be selected and awarded with $5,000 per runner-up and publication of their essay in Science (online). The winner and the runners-up will be invited to attend the formal award ceremony. View eligibility and application information>
The results are especially impressive given that study participants had received multiple earlier treatments for ovarian cancer, and therefore represented an especially hard-to-treat group, trial leaders say. Case CCC member Steven Waggoner, MD is a co-author of the study.
NIH BULLETIN - Notices and Funding Opportunities
Notice to Extend the Expiration Date for PAR-18-207 "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)"

Notice of Special Interest (NOSI): Availability of Administrative Supplements for Enhancing Utility and Usage of Common Fund Data Sets
Mon, July 8
Shared Resources Directors Meeting
12p WRB 1-422D

WRB Faculty Meetings with Stan Gerson
3p WRB 3-136
Thurs, July 11
Developmental Therapeutics Journal Club
9a NE6-218

Molecular Biology and Microbiology Virology Journal Club
1p SOM W203
Fri, July 12
UH Seidman Cancer Center Grand Rounds
8a Wearn 137

Center of Excellence Retreat in Lymphoid Malignancies Research
Contact Becky Habecker to RSVP at
8a-4:30p Intercontinental
Tues, July 16
Cancer Impact Lecture
Mohamed Abazeed, MD, PhD
1p NE1-205
Thurs, July 18
Developmental Therapeutics Journal Club
9a NE6-218

Molecular Biology and Microbiology Virology Journal Club
1p SOM W203
Fri, July 19
VeloSano Bike To Cure Weekend

Deadline: Open

Deadline: Open

Deadline: Open
Case Comprehensive Cancer Center